Back
NovoCure Vs. NeuroMetrix Industry Stock Comparison
Sell
40
NVCR
NovoCure
Last Price:
12.64
Seasonality Move:
12.01%
Sell
46
NURO
NeuroMetrix
Last Price:
4.45
Seasonality Move:
13.67%
Sell
40
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.64. The Score for NVCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
NeuroMetrix (NURO)
is a Sell
Is NeuroMetrix a Buy, Sell or Hold?
- The current NeuroMetrix [NURO] share price is $4.44. The Score for NURO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NURO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NURO Stock Price Chart
What is NeuroMetrix's stock price today?
-
The NeuroMetrix share price today is $4.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NURO is experiencing slight selling pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 42.98 | Sell |
| Chaikin Money Flow: | 725639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.29 - 14.59) | Sell |
| Bollinger Bands (100): | (12.92 - 15.44) | Sell |
NURO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 62.82 | Buy |
| Chaikin Money Flow: | -5667 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.69 - 4.31) | Buy |
| Bollinger Bands (100): | (3.19 - 3.99) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.16 | Buy |
| 20-day SMA: | 13.31 | Sell |
| 50-day SMA: | 14.43 | Sell |
| 200-day SMA: | 17.67 | Sell |
| 8-day EMA: | 12.44 | Buy |
| 20-day EMA: | 13.04 | Sell |
| 50-day EMA: | 13.84 | Sell |
| 200-day EMA: | 22.63 | Sell |
NURO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.22 | Buy |
| 20-day SMA: | 3.96 | Buy |
| 50-day SMA: | 3.87 | Buy |
| 200-day SMA: | 4.56 | Sell |
| 8-day EMA: | 4.25 | Buy |
| 20-day EMA: | 4.06 | Buy |
| 50-day EMA: | 3.88 | Buy |
| 200-day EMA: | 5.42 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
NeuroMetrix Earnings Growth & NURO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroMetrix Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||